primary liver cancer
Conditions
Interventions
Group A:Pure surgery therapy
Group B:Pure RFA treatment
Sponsors
Shanghai Eastern Hepatobiliary Surgery Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed HCC pathologically, and confirmed recurrent HCC through ultrasonic B, CT, MRI or DSA test; 2. Has a good condition in vital organs such as heart, lung, and kidney; 3. Has a good liver function: Child A level, or nearly A level after hepato-protection treatment; 4. Solitary small cancer focus (diameter <5cm), or the number of recurrent HCC focus is no more than three and all of them grow in the same lobe of liver.
Exclusion criteria
Exclusion criteria: 1. Subjects refuse to participate in this study; 2. Subjects cannot be followed up regularly; 3. Subjects with severe heart, lung, kidney diseases; 4. Subjects with liver CP level B or C, and serum creatinine >=2*ULN; 5. Subjects with severe bone marrow depression, such as neutrophil counting is lower than 1.5*10^9. 6. Subjects with jaundice (not including jaundice in the bile ducts); 7. Subjects with ascites or extensive metastasis outside the liver; 8. Subjects with invasion to portal vein.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival rate, Mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Non-tumor life span, intra-liver recurrence rate,; | — |
Countries
China
Contacts
Public ContactYang Jiahe, Qian Guojun
Outcome results
None listed